Lessons from large clinical trials in managing COPD patients

Marc Miravitlles, Antonio R Anzueto

Research output: Contribution to journalArticle

Abstract

Large, multicenter, randomized controlled trials in COPD have recently been completed. The largest of these studies are "Towards a Revolution in COPD Health" (TORCH) and "Understanding Potential Long-Term impacts on Function with Tiotropium" (UPLiFT®). These studies make considerable contributions to understanding the natural history of COPD. The objective of this article is to review the data from these different trials in order to find what can be learnt of the management of COPD. The long-term improvements in lung function, health-related quality of life, and possibly survival from the use of long-acting bronchodilators in these trials suggest an influence on the progression of the disease.

Original languageEnglish (US)
Pages (from-to)130-139
Number of pages10
JournalTurk Toraks Dergisi
Volume10
Issue number3
StatePublished - Sep 2009

Fingerprint

Chronic Obstructive Pulmonary Disease
Clinical Trials
Bronchodilator Agents
Disease Progression
Randomized Controlled Trials
Quality of Life
Lung
Survival
Health

Keywords

  • Bronchodilators
  • FEV
  • Fluticasone
  • Inhaled corticosteroids
  • Long-acting anticholinergics
  • Long-acting beta agonists
  • Lung function
  • Mortality
  • Salmeterol
  • Tiotropium

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lessons from large clinical trials in managing COPD patients. / Miravitlles, Marc; Anzueto, Antonio R.

In: Turk Toraks Dergisi, Vol. 10, No. 3, 09.2009, p. 130-139.

Research output: Contribution to journalArticle

@article{e1db259193224e48833ed908308bb8cb,
title = "Lessons from large clinical trials in managing COPD patients",
abstract = "Large, multicenter, randomized controlled trials in COPD have recently been completed. The largest of these studies are {"}Towards a Revolution in COPD Health{"} (TORCH) and {"}Understanding Potential Long-Term impacts on Function with Tiotropium{"} (UPLiFT{\circledR}). These studies make considerable contributions to understanding the natural history of COPD. The objective of this article is to review the data from these different trials in order to find what can be learnt of the management of COPD. The long-term improvements in lung function, health-related quality of life, and possibly survival from the use of long-acting bronchodilators in these trials suggest an influence on the progression of the disease.",
keywords = "Bronchodilators, FEV, Fluticasone, Inhaled corticosteroids, Long-acting anticholinergics, Long-acting beta agonists, Lung function, Mortality, Salmeterol, Tiotropium",
author = "Marc Miravitlles and Anzueto, {Antonio R}",
year = "2009",
month = "9",
language = "English (US)",
volume = "10",
pages = "130--139",
journal = "Turk Toraks Dergisi",
issn = "1302-7808",
publisher = "Aves",
number = "3",

}

TY - JOUR

T1 - Lessons from large clinical trials in managing COPD patients

AU - Miravitlles, Marc

AU - Anzueto, Antonio R

PY - 2009/9

Y1 - 2009/9

N2 - Large, multicenter, randomized controlled trials in COPD have recently been completed. The largest of these studies are "Towards a Revolution in COPD Health" (TORCH) and "Understanding Potential Long-Term impacts on Function with Tiotropium" (UPLiFT®). These studies make considerable contributions to understanding the natural history of COPD. The objective of this article is to review the data from these different trials in order to find what can be learnt of the management of COPD. The long-term improvements in lung function, health-related quality of life, and possibly survival from the use of long-acting bronchodilators in these trials suggest an influence on the progression of the disease.

AB - Large, multicenter, randomized controlled trials in COPD have recently been completed. The largest of these studies are "Towards a Revolution in COPD Health" (TORCH) and "Understanding Potential Long-Term impacts on Function with Tiotropium" (UPLiFT®). These studies make considerable contributions to understanding the natural history of COPD. The objective of this article is to review the data from these different trials in order to find what can be learnt of the management of COPD. The long-term improvements in lung function, health-related quality of life, and possibly survival from the use of long-acting bronchodilators in these trials suggest an influence on the progression of the disease.

KW - Bronchodilators

KW - FEV

KW - Fluticasone

KW - Inhaled corticosteroids

KW - Long-acting anticholinergics

KW - Long-acting beta agonists

KW - Lung function

KW - Mortality

KW - Salmeterol

KW - Tiotropium

UR - http://www.scopus.com/inward/record.url?scp=77953378871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953378871&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953378871

VL - 10

SP - 130

EP - 139

JO - Turk Toraks Dergisi

JF - Turk Toraks Dergisi

SN - 1302-7808

IS - 3

ER -